UPDATE: Baird Downgrades Tandem Diabetes Care to Neutral, Raises Price Target to $75 As Firm Notes 3 Potential Catalysts:

1. MDI share capture could become more challenging 2. Beta could be 2021 wildcard. 3. MDT share gains could also face headwinds

Benzinga · 02/04/2020 16:04

1. MDI share capture could become more challenging

2. Beta could be 2021 wildcard.

3. MDT share gains could also face headwinds